Ideaya Biosciences Inc

Research Ideaya Biosciences Inc (IDYA) on Bullrun: market cap USD 3.21B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerIDYA
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 3.21B
• Financial periodFY2025
• RevenueUSD 218.71M
• Revenue growth3024.4%
• Net income-USD 113.70M
• Free cash flow-USD 73.47M

Valuation Snapshot

latest market cap is USD 3.21B.

About Ideaya Biosciences Inc

IDEAYA Biosciences, Inc., a precision medicine oncology company, develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States. The company offers Darovasertib, an oral, potent, and selective protein kinase, C (PKC) inhibitor for the treatment of uveal melanoma, ocular cancer, and is being evaluated in multiple clinical trials as monotherapy and in combination with crizotinib for metastatic, neoadjuvant, and adjuvant settings.

Frequently asked questions

What is Ideaya Biosciences Inc's market cap?

Ideaya Biosciences Inc's market capitalization is USD 3.21B.

What does Ideaya Biosciences Inc do?

IDEAYA Biosciences, Inc., a precision medicine oncology company, develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States.